AI
IMNM icon

Atom Investors’s Immunome IMNM Stock Holding History

Atom Investors’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.3M Sell
297,489
-9,391
-3% -$201K 0.56% 14
2026
Q1 		$6.71M Buy
306,880
+131,113
+75% +$2.92M 0.48% 38
2025
Q4 		$3.78M Buy
+175,767
New +$3.08M 0.3% 115
2022
Q2 		– Sell
-39,770
Closed -$226K – 287
2022
Q1 		$226K Sell
39,770
-6,088
-13% -$45.5K 0.11% 161
2021
Q4 		$594K Buy
+45,858
New +$818K 0.1% 148

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Atom Investors's IMNM Position: Q2 2026 in Review

Atom Investors reduced its Immunome (IMNM) stake by 3.1% in Q2 2026, selling an estimated $201K and leaving 297,489 shares worth $6.3M. The position accounts for 0.56% of the portfolio, ranked #14.

Atom Investors first reported a position in IMNM in Q4 2021 and has held it in 5 quarters since. The position peaked at $6.71M in Q1 2026. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Atom Investors held 297,489 shares of Immunome worth $6.3M as of Q2 2026.
  • Atom Investors sold 9,391 Immunome shares in Q2 2026, an estimated $201K.
  • Immunome made up 0.56% of Atom Investors's portfolio in Q2 2026, its #14 holding.
  • Atom Investors first reported a position in Immunome in Q4 2021 and has held it in 5 quarters since.
  • Atom Investors's Immunome position peaked at $6.71M in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.